SK53699A3 - 6-{3-[4-(fluorobenzyle)-piperidine-1-yl]-propionyl}-3h- -benzoxazole-2-one, method for its preparation, its use and pharmaceutical composition containing the same - Google Patents

6-{3-[4-(fluorobenzyle)-piperidine-1-yl]-propionyl}-3h- -benzoxazole-2-one, method for its preparation, its use and pharmaceutical composition containing the same Download PDF

Info

Publication number
SK53699A3
SK53699A3 SK536-99A SK53699A SK53699A3 SK 53699 A3 SK53699 A3 SK 53699A3 SK 53699 A SK53699 A SK 53699A SK 53699 A3 SK53699 A3 SK 53699A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
physiologically acceptable
propionyl
acceptable salts
Prior art date
Application number
SK536-99A
Other languages
English (en)
Slovak (sk)
Inventor
Helmut Prucher
Rudolf Gottschlich
Joachim Leibrock
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK53699A3 publication Critical patent/SK53699A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK536-99A 1996-10-30 1997-10-10 6-{3-[4-(fluorobenzyle)-piperidine-1-yl]-propionyl}-3h- -benzoxazole-2-one, method for its preparation, its use and pharmaceutical composition containing the same SK53699A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19643790A DE19643790A1 (de) 1996-10-30 1996-10-30 Benzoxazol-Derivat
PCT/EP1997/005590 WO1998018793A1 (de) 1996-10-30 1997-10-10 Benzoxazolderivat mit affinität zu bindungsstellen von aminosäurerezeptoren

Publications (1)

Publication Number Publication Date
SK53699A3 true SK53699A3 (en) 2000-03-13

Family

ID=7809592

Family Applications (1)

Application Number Title Priority Date Filing Date
SK536-99A SK53699A3 (en) 1996-10-30 1997-10-10 6-{3-[4-(fluorobenzyle)-piperidine-1-yl]-propionyl}-3h- -benzoxazole-2-one, method for its preparation, its use and pharmaceutical composition containing the same

Country Status (16)

Country Link
EP (1) EP0938485A1 (ko)
JP (1) JP2001502713A (ko)
KR (1) KR20000052876A (ko)
CN (1) CN1235604A (ko)
AR (1) AR008512A1 (ko)
AU (1) AU4946597A (ko)
BR (1) BR9712577A (ko)
CA (1) CA2270359A1 (ko)
CZ (1) CZ147999A3 (ko)
DE (1) DE19643790A1 (ko)
HU (1) HUP9904547A3 (ko)
NO (1) NO992063L (ko)
PL (1) PL332771A1 (ko)
SK (1) SK53699A3 (ko)
WO (1) WO1998018793A1 (ko)
ZA (1) ZA979725B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
DE19812331A1 (de) * 1998-03-20 1999-09-23 Merck Patent Gmbh Piperidinderivate
PE20000728A1 (es) 1998-06-26 2000-08-21 Cocensys Inc Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
EP1674087A1 (en) 2000-10-02 2006-06-28 Pfizer Products Inc. Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists
DE10120159A1 (de) * 2001-04-25 2002-10-31 Merck Patent Gmbh NMDA-Antagonisten und NMDA-Agonisten zur Behandlung von Suchterkrankungen
SI1409477T1 (sl) 2001-07-24 2009-02-28 Richter Gedeon Nyrt Derivati piperidina kot antagonisti nmda-receptorjev
DE102007047737A1 (de) * 2007-10-05 2009-04-30 Merck Patent Gmbh Piperidin- und Piperazinderivate
DE102009049211A1 (de) 2009-10-13 2011-04-28 Merck Patent Gmbh Sulfoxide
CN103974698A (zh) 2011-11-22 2014-08-06 加利福尼亚大学董事会 用于治疗缺血性损伤的半胱胺和/或胱胺

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0709384T3 (da) * 1994-10-31 1999-08-23 Merck Patent Gmbh Benzylpiperidinderivater med høj affinitet til aminosyrereceptorers bindingssteder

Also Published As

Publication number Publication date
ZA979725B (en) 1998-05-22
BR9712577A (pt) 1999-10-19
EP0938485A1 (de) 1999-09-01
PL332771A1 (en) 1999-10-11
CN1235604A (zh) 1999-11-17
NO992063D0 (no) 1999-04-29
JP2001502713A (ja) 2001-02-27
CZ147999A3 (cs) 1999-08-11
HUP9904547A3 (en) 2001-01-29
CA2270359A1 (en) 1998-05-07
AR008512A1 (es) 2000-01-19
KR20000052876A (ko) 2000-08-25
WO1998018793A1 (de) 1998-05-07
HUP9904547A2 (hu) 2000-12-28
DE19643790A1 (de) 1998-05-07
NO992063L (no) 1999-04-29
AU4946597A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
EP1485363B1 (de) Cyclische amide
EP1497279B1 (de) Substituierte indole und deren verwendung als 5ht-wiederaufnahme inhibitoren und als 5ht liganden
CA2324339C (en) Piperidine derivatives
NO323544B1 (no) Ureaforbindelser med muskarinisk reseptor-antagonistaktivitet, farmasoytiske preparater omfattende disse, anvendelse av forbindelsene, samt mellomprodukter.
JP3834098B2 (ja) ベンゾニトリル類およびベンゾフルオリド類
KR20070038502A (ko) Nmda 수용체 길항물질인 인돌-2-카르복사미딘 유도체
SK53699A3 (en) 6-{3-[4-(fluorobenzyle)-piperidine-1-yl]-propionyl}-3h- -benzoxazole-2-one, method for its preparation, its use and pharmaceutical composition containing the same
EP1124824B1 (de) Chromenon- und chromanonderivate als integrinhemmer
CN105712985A (zh) β-内酰胺后叶加压素V1a拮抗剂
EP1572646A1 (de) N-(indolethyl-)cycloamin-verbindungen
AU2008225014B2 (en) Dibenzo(b,f)(1,4)oxazapine compounds
JP3057095B2 (ja) イサチン誘導体、その製造方法及びその使用方法
EP0635505B1 (de) 4-Aryloxy- und 4-Arylthiopiperidin-derivate
CZ231898A3 (cs) Derivát 1-(pyrazol-3-ylethyl)-4-(indol-3-yl)piperidinu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
CZ291446B6 (cs) Derivát piperidinylmethyloxazolidinonu a farmaceutický prostředek, který ho obsahuje
DE102006025317A1 (de) Isoindolin-1-on-,Isoindolin-3-on und Isoindolin-1,3-dion-Derivate und ihre Verwendung
WO2006072349A1 (de) Thiophen-substituierte pyrazoline
MXPA99003834A (en) Benzoxazole derivative with an affinity to binding sites of amino acid receptors
MXPA00009090A (en) 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists
CZ20003404A3 (cs) Derivát l-(3-heteroarylpropyl-nebo-prop-2-enyl)- 4-benzylpiperidinu jakožto antagonist NMDA receptoru, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje